• If you are wondering whether IQVIA Holdings is attractively priced or looking stretched, this article breaks down what the current share price might imply about value.
• The stock last closed at US$171.28, with the share price up 2.0% over the past month but down 24.0% year to date and 29.8% over five years. The 1 year return stands at 8.0% and the 3 year return shows a 20.2% decline.
• Recent coverage around IQVIA Holdings has focused on its role in life sciences data and clinical services, as investors assess how that positioning fits into broader sector trends. This context helps explain why the stock's performance has been mixed across different timeframes, as sentiment can shift when attention moves between growth prospects and valuation.
• On Simply Wall St's 6 point valuation check, IQVIA Holdings scores a full 6/6. The rest of this article will compare what different valuation methods suggest about the stock, and a more holistic way to think about valuation will be saved for the conclusion.

Approach 1: IQVIA Holdings Discounted Cash Flow (DCF) Analysis

A Discounted Cash Flow, or DCF, model estimates what a stock might be worth by projecting the cash the company could generate in the future and discounting those cash flows back to today. For IQVIA Holdings, this uses a 2 Stage Free Cash Flow to Equity model.

IQVIA Holdings recently reported last twelve month free cash flow of about $2.06b. Analyst and extrapolated projections supplied to the model show free cash flow rising to around $3.06b by 2030, with a series of annual estimates between 2026 and 2035 that are discounted back to reflect the time value of money and equity risk. All cash flows are assessed in dollar terms.

When these projected cash flows are added together and adjusted for the second stage of the model, Simply Wall St arrives at an estimated intrinsic value of about $296.11 per share. Compared to the latest share price of $171.28, this implies the stock trades at a discount of roughly 42.2%, which indicates that IQVIA Holdings is priced below this DCF estimate.

Result: UNDERVALUED

Our Discounted Cash Flow (DCF) analysis suggests IQVIA Holdings is undervalued by 42.2%. Track this in your watchlist or portfolio, or discover 44 more high quality undervalued stocks.

Approach 2: IQVIA Holdings Price vs Earnings

For profitable companies like IQVIA Holdings, the P/E ratio is a useful way to gauge how much investors are currently paying for each dollar of earnings. It links the share price directly to earnings, which many investors watch closely.

What counts as a "normal" or "fair" P/E depends on how the market views a company's growth prospects and risk. Higher expected growth or lower perceived risk can support a higher P/E, while lower growth or higher risk typically justifies a lower multiple.

IQVIA Holdings is trading on a P/E of 20.64x. This sits below the Life Sciences industry average P/E of 34.47x and the selected peer group average of 44.44x. Simply Wall St also provides a Fair Ratio of 23.08x, which is the P/E level that might be expected given factors such as IQVIA Holdings earnings growth profile, profit margins, industry, market cap and company specific risks.

This Fair Ratio can be more useful than a simple comparison with industry or peers because it adjusts for those company specific characteristics rather than assuming all competitors deserve similar multiples. With the actual P/E of 20.64x sitting below the Fair Ratio of 23.08x, the stock screens as undervalued on this measure.

Result: UNDERVALUED

P/E ratios tell one story, but what if the real opportunity lies elsewhere? Start investing in legacies, not executives. Discover our 20 top founder-led companies.

Upgrade Your Decision Making: Choose your IQVIA Holdings Narrative

Earlier it was mentioned that there is an even better way to think about valuation. On Simply Wall St this takes the form of Narratives, which let you connect your view of IQVIA Holdings business, such as how AI projects, data privacy rules, clinical trial demand, margins or debt might play out, to a financial forecast and a fair value that you can compare with the current share price to help decide whether the stock looks appealing or expensive at any point in time.

In practice, a Narrative is a short story that sits behind the numbers. It links assumptions about future revenue, earnings and margins to a fair value that automatically refreshes when new data, news or earnings arrive. Within the Simply Wall St Community page you can see Narratives from millions of other investors, ranging from a more optimistic view that IQVIA Holdings could justify a fair value around US$290.00 to a more cautious view closer to US$195.00. You can then decide which story best matches your own expectations and risk tolerance.

Do you think there's more to the story for IQVIA Holdings? Head over to our Community to see what others are saying!

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.